Article ; Online: A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing.
Research and practice in thrombosis and haemostasis
2022 Volume 6, Issue 4, Page(s) e12739
Abstract: Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis ...
Abstract | Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis and therefore should not be part of thrombophilia testing. Eliminating MTHFR from thrombophilia testing will reduce patient concerns and health care costs. |
---|---|
Language | English |
Publishing date | 2022-06-08 |
Publishing country | United States |
Document type | Journal Article |
ISSN | 2475-0379 |
ISSN (online) | 2475-0379 |
DOI | 10.1002/rth2.12739 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.